Pricing Log in Create free account

Alpha Tau Medical Ltd. (DRTS) vs Inhibrx Biosciences, Inc. (INBX)

Alpha Tau Medical Ltd. and Inhibrx Biosciences, Inc. are both Biotechnology companies. Alpha Tau Medical Ltd. and Inhibrx Biosciences, Inc. are of similar size ($1.2B and $1.2B). Across the 9 metrics below, Alpha Tau Medical Ltd. leads on 6 and Inhibrx Biosciences, Inc. on 3.

Valuation

Metric DRTS INBX Biotechnology median
P/E n/m n/m 10.60
P/S n/m 424.97 9.40
P/B 27.96 n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m 438.60 9.02
Earnings yield (4.08%) (10.39%) (32.88%)
Free cash flow yield (3.17%) (9.85%) (23.13%)

Profitability

Metric DRTS INBX Biotechnology median
Gross margin 0.00% 100.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 0.00% (1,773.60%) (51.96%)
Return on assets 0.00% (75.44%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DRTS INBX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) (17.78%) (108.03%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric DRTS INBX Biotechnology median
Debt to equity 0.15 (3.33) 0.00
Current ratio 11.09 5.07 4.97
Net debt to EBITDA 1.63 0.18 1.01

Dividend

Metric DRTS INBX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric DRTS INBX Biotechnology median
Market cap 1.23b 1.18b 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack